WASHINGTON, Sept. 30 /PRNewswire-FirstCall/ -- Syngenta announced a multi-year agreement with Metabolon for biochemical profiling technology that will enhance the Syngenta technical toolkit for its seeds research programs. This agreement will support Syngenta researchers' understanding of plants' response to environmental conditions and decisions on crop traits earlier in the development cycle.
"Biochemical profiling is becoming an important part of Syngenta's focused program to apply the full range of cutting-edge science to supply solutions for growers," said Roger Kemble, Ph.D., Head, Syngenta Crop Genetics Research. "Metabolon's technology will enable Syngenta's insights to the performance of our products as we focus in bringing the next generations of seed science across native traits and GM paths to unlock crop productivity."
"We are excited to expand our partnership with Syngenta, a leading seed biotechnology company," said John Ryals, Ph.D., president and chief executive of Metabolon. "This agreement brings Syngenta into our growing stable of commercial partners in the pharmaceutical, biotechnology and consumer product sectors and we look forward to providing further actionable insight with our global biochemical analysis."
This agreement expands upon initial studies performed by Metabolon for Syngenta to test the application of the technology. Financial terms of the agreement were not disclosed.
Syngenta is a world-leading agribusiness committed to sustainable agriculture through innovative research and technology. The company is a leader in crop protection, and ranks third in the high-value commercial seeds market. Sales in 2007 were approximately $9.2 billion. Syngenta employs over 21,000 people in more than 90 countries. Syngenta is listed on the Swiss stock exchange (SYNN) and in New York (SYT). Further information is available at http://www.syngenta.com.
Cautionary Statement Regarding Forward-Looking Statements
This document contains forward-looking statements, which can be
identified by terminology such as 'expect', 'would', 'will', 'potential',
'plans', 'prospects', 'estimated', 'aiming', 'on track' and similar
expressions. Such statements may be subject to risks and uncertainties that
could cause the actual results to differ materially from these statements.
We refer you to Syngenta's publicly available filings with the U.S.
Securities and Exchange Commission for information about these and other
risks and uncertainties. Syngenta assumes no obligation to update
forward-looking statements to reflect actual results, changed assumptions
or other factors. This document does not constitute, or form part of, any
offer or invitation to sell or issue, or any solicitation of any offer, to
purchase or subscribe for any ordinary shares in Syngenta AG, or Syngenta
ADSs, nor shall it form the basis of, or be relied on in connection with,
any contract therefor.
202 628 2372
Copyright©2008 PR Newswire.
All rights reserved